Stratos Wealth Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.62M Sell
15,770
-8,765
-36% -$2.33M 0.08% 260
2026
Q1
$2.69M Sell
24,535
-30
-0.1% -$4.27K 0.03% 482
2025
Q4
$4.09M Buy
24,565
+4,104
+20% +$687K 0.05% 372
2025
Q3
$4.01M Sell
20,461
-4,942
-19% -$813K 0.05% 371
2025
Q2
$2.3M Buy
25,403
+2,080
+9% +$164K 0.03% 458
2025
Q1
$1.39M Buy
23,323
+13,562
+139% +$1.25M 0.02% 550
2024
Q4
$1.29M Sell
9,761
-1,863
-16% -$175K 0.02% 602
2024
Q3
$609K Buy
+11,624
New +$546K 0.01% 865

Other funds holding ALAB

Stratos Wealth Partners's ALAB Position: Q2 2026 in Review

Stratos Wealth Partners reduced its Astera Labs (ALAB) stake by 36% in Q2 2026, selling an estimated $2.33M and leaving 15,770 shares worth $7.62M. The position accounts for 0.08% of the portfolio, ranked #260.

Stratos Wealth Partners first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Stratos Wealth Partners held 15,770 shares of Astera Labs worth $7.62M as of Q2 2026.
  • Stratos Wealth Partners sold 8,765 Astera Labs shares in Q2 2026, an estimated $2.33M.
  • Astera Labs made up 0.08% of Stratos Wealth Partners's portfolio in Q2 2026, its #260 holding.
  • Stratos Wealth Partners first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.